Clinical Trials › NCT05893225
Active, Not RecruitingPhase 2
Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And Neurodegeneration
Sponsored by University Hospital, Antwerp
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 120
Target enrollment
Nov 2023
Start date
Feb 2027
Expected completion
Interventions / Treatments
Metformin Hydrochloride 850 mg Oral TabletPlacebo
Conditions studied
Multiple SclerosisPrimary Progressive Multiple SclerosisSecondary-progressive Multiple Sclerosis
Trial locations
U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.
More Phase 2 trials
Browse all Phase 2 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.